Evan Seigerman
Stock Analyst at BMO Capital
(4.41)
# 1,140
Out of 4,345 analysts
967
Total ratings
51.6%
Success rate
7.3%
Average return
Main Sectors:
Stocks Rated by Evan Seigerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Rated: Buy | $1,300 | $1,082.92 | +20.05% | 114 | May 26, 2026 | |
| TSHA Taysha Gene Therapies | Rated: Buy | $8 → $10 | $5.75 | +73.91% | 6 | May 22, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $730 | $627.74 | +16.29% | 76 | May 21, 2026 | |
| PFE Pfizer | Maintained: Buy | $34 | $26.21 | +29.72% | 50 | May 20, 2026 | |
| BIIB Biogen | Maintained: Hold | $196 | $196.97 | -0.49% | 60 | May 14, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $60 | $57.52 | +4.31% | 66 | May 13, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $26 → $34 | $21.19 | +60.45% | 8 | May 11, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Hold | $144 | $155.83 | -7.59% | 45 | May 11, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | $36 → $45 | $44.55 | +1.01% | 47 | May 11, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $128 | $93.00 | +37.63% | 13 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $5.44 | +28.68% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $24 | $13.24 | +81.27% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $69.76 | +43.35% | 29 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 | $336.06 | +19.03% | 66 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $75 | $97.34 | -22.95% | 48 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 | $120.24 | +12.28% | 45 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $437.22 | +37.23% | 67 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $258 | $215.40 | +19.78% | 25 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $11 → $1 | $4.70 | -78.72% | 30 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $174 | $133.69 | +30.15% | 76 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $50.71 | +38.04% | 9 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $145 | $39.54 | +266.72% | 19 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $72 → $112 | $102.21 | +9.58% | 4 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $26.87 | - | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.83 | - | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.74 | n/a | 1 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €113.44 → €128.91 | $129.50 | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.05 | n/a | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.74 | n/a | 3 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $27 | $5.89 | n/a | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €135.00 → €129.00 | $24.20 | n/a | 6 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.69 → $0.84 | $0.8094 | n/a | 6 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $30 | $4.38 | n/a | 4 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $169 → $220 | $27.70 | n/a | 2 | Feb 24, 2020 |
Eli Lilly and Company
May 26, 2026
Rated: Buy
Price Target: $1,300
Current: $1,082.92
Upside: +20.05%
Taysha Gene Therapies
May 22, 2026
Rated: Buy
Price Target: $8 → $10
Current: $5.75
Upside: +73.91%
Regeneron Pharmaceuticals
May 21, 2026
Maintained: Buy
Price Target: $730
Current: $627.74
Upside: +16.29%
Pfizer
May 20, 2026
Maintained: Buy
Price Target: $34
Current: $26.21
Upside: +29.72%
Biogen
May 14, 2026
Maintained: Hold
Price Target: $196
Current: $196.97
Upside: -0.49%
Bristol-Myers Squibb Company
May 13, 2026
Maintained: Hold
Price Target: $60
Current: $57.52
Upside: +4.31%
ACADIA Pharmaceuticals
May 11, 2026
Maintained: Buy
Price Target: $26 → $34
Current: $21.19
Upside: +60.45%
Neurocrine Biosciences
May 11, 2026
Maintained: Hold
Price Target: $144
Current: $155.83
Upside: -7.59%
Novo Nordisk
May 11, 2026
Maintained: Hold
Price Target: $36 → $45
Current: $44.55
Upside: +1.01%
BioNTech SE
May 11, 2026
Maintained: Buy
Price Target: $128
Current: $93.00
Upside: +37.63%
May 11, 2026
Maintained: Buy
Price Target: $7
Current: $5.44
Upside: +28.68%
May 5, 2026
Maintained: Buy
Price Target: $32 → $24
Current: $13.24
Upside: +81.27%
May 5, 2026
Reiterated: Buy
Price Target: $100
Current: $69.76
Upside: +43.35%
May 4, 2026
Maintained: Buy
Price Target: $400
Current: $336.06
Upside: +19.03%
May 4, 2026
Maintained: Sell
Price Target: $75
Current: $97.34
Upside: -22.95%
May 4, 2026
Maintained: Buy
Price Target: $135
Current: $120.24
Upside: +12.28%
May 4, 2026
Maintained: Buy
Price Target: $600
Current: $437.22
Upside: +37.23%
May 4, 2026
Maintained: Buy
Price Target: $258
Current: $215.40
Upside: +19.78%
Apr 13, 2026
Downgraded: Sell
Price Target: $11 → $1
Current: $4.70
Upside: -78.72%
Apr 7, 2026
Maintained: Buy
Price Target: $160 → $174
Current: $133.69
Upside: +30.15%
Mar 18, 2026
Reiterated: Buy
Price Target: $70
Current: $50.71
Upside: +38.04%
Mar 16, 2026
Reiterated: Buy
Price Target: $130 → $145
Current: $39.54
Upside: +266.72%
Oct 13, 2025
Maintained: Buy
Price Target: $72 → $112
Current: $102.21
Upside: +9.58%
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $26.87
Upside: -
Sep 30, 2025
Rated: Hold
Price Target: n/a
Current: $8.83
Upside: -
May 6, 2025
Rated: Hold
Price Target: n/a
Current: $3.74
Upside: n/a
Oct 23, 2024
Maintained: Buy
Price Target: €113.44 → €128.91
Current: $129.50
Upside: n/a
Aug 7, 2023
Rated: Hold
Price Target: n/a
Current: $8.05
Upside: n/a
May 9, 2023
Rated: Hold
Price Target: n/a
Current: $4.74
Upside: n/a
Aug 13, 2021
Maintained: Buy
Price Target: $30 → $27
Current: $5.89
Upside: n/a
Oct 16, 2020
Maintained: Hold
Price Target: €135.00 → €129.00
Current: $24.20
Upside: n/a
Aug 13, 2020
Reiterated: Sell
Price Target: $0.69 → $0.84
Current: $0.8094
Upside: n/a
May 11, 2020
Reiterated: Buy
Price Target: $13 → $30
Current: $4.38
Upside: n/a
Feb 24, 2020
Maintained: Hold
Price Target: $169 → $220
Current: $27.70
Upside: n/a